Post-progression survival after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor for advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.

被引：0
|
作者：
Kogure, Yoshihito
Kitagawa, Chiyoe
Oki, Masahide
Saka, Hideo
机构：
[1] Nagoya Med Ctr, Nagoya, Aichi, Japan
[2] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19005
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epidermal growth factor receptor mutations in patients with non-small cell lung cancer
    Johnson, BE
    Jänne, PA
    CANCER RESEARCH, 2005, 65 (17) : 7525 - 7529
  • [32] Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Goag, Eun Kyong
    Lee, Jung Mo
    Chung, Kyung Soo
    Kim, Song Yee
    Leem, Ah Young
    Song, Joo Han
    Jung, Ji Ye
    Park, Moo Suk
    Chang, Yoon Soo
    Kim, Young Sam
    Chang, Joon
    Kim, Eun Young
    JOURNAL OF CANCER, 2018, 9 (06): : 1113 - 1120
  • [33] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [34] Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer
    Noda, Shoko
    Kanda, Shintaro
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (05) : 547 - 556
  • [35] Feasibility of Rebiopsy in Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
    Hasegawa, Takaaki
    Sawa, Toshiyuki
    Futamura, Yohei
    Horiba, Akane
    Ishiguro, Takashi
    Marui, Tsutomu
    Yoshida, Tsutomu
    INTERNAL MEDICINE, 2015, 54 (16) : 1977 - 1980
  • [36] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
    Jamal-Hanjani, Mariam
    Spicer, James
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 938 - 944
  • [37] Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (05) : 249 - 257
  • [38] Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma
    Yamaura, Takumi
    Muto, Satoshi
    Mine, Hayato
    Takagi, Hironori
    Watanabe, Masayuki
    Ozaki, Yuki
    Inoue, Takuya
    Fukuhara, Mitsuro
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Osugi, Jun
    Hoshino, Mika
    Higuchi, Mitsunori
    Shio, Yutaka
    Suzuki, Hiroyuki
    ONCOLOGY LETTERS, 2020, 19 (06) : 4169 - 4176
  • [39] Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Cancer Database
    Okuma, Yusuke
    Shintani, Yasushi
    Sekine, Ikuo
    Shukuya, Takehito
    Takayama, Koichi
    Inoue, Akira
    Okamoto, Isamu
    Kiura, Katsuyuki
    Yamamoto, Nobuyuki
    Kawaguchi, Tomoya
    Miyaoka, Etsuo
    Yoshino, Ichiro
    Date, Hiroshi
    CLINICAL LUNG CANCER, 2024, 25 (04) : 336 - 346.e2
  • [40] The efficacy of upfront craniocerebral radiotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors in patients with epidermal growth factor receptor-positive non-small cell lung cancer with brain metastases
    Zhou, Jianxi
    Zhou, Yingnan
    Sun, Yunchuan
    Xiao, Li
    Lu, Hongling
    Yin, Xiaoming
    Fan, Kui
    FRONTIERS IN ONCOLOGY, 2024, 13
12345